PerspectiveBiomedicine

Lowering LDL--Not Only How Low, But How Long?

Science  24 Mar 2006:
Vol. 311, Issue 5768, pp. 1721-1723
DOI: 10.1126/science.1125884

You are currently viewing the summary.

View Full Text

Summary

People with a mutation in a proteolytic enzyme are at a substantially lower risk for coronary heart disease because of their lifelong reduction of plasma low-density lipoprotein.

Cited By...